GlassScriptPhysician profile
Nicholas David Lancaster
NPI 1063776102
$699.85
in general payments reported to CMS, 2019-2025
9 companies · $62.91 in 2025
The $62.91 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.87 · 2020: $149 · 2021: $227 · 2022: $34.45 · 2023: $134 · 2025: $62.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $452.68 | 2019-2025 | Tecnis Iol, Tecnis Iol |
| Alcon Vision LLC | $83.37 | 2020-2023 | Clareon |
| Staar Surgical Company | $29.50 | 2019 | |
| Rxsight INC | $27.37 | 2021 | |
| Glaukos Corporation | $25.36 | 2025 | Istent Infinite, Idosetr |
| Beaver-Visitec International, INC. | $23.05 | 2023 | |
| Biotissue Holdings INC. | $21.26 | 2021 | |
| Abbvie INC. | $19.99 | 2025 | |
| Omeros Corporation | $17.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Lancaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.